TongliBio reaches a strategic partnership with Occam Biolabs, Inc.
Time：2020-05-02
5/2/2020. TongliBio reaches a strategic partnership with Occam Biolabs, Inc. in US to co-develop in vitro diagnostic kit for Covid-19 and other zoonoses. Occam Biolabs has developed a proprietary MOES platform technology for molecular diagnostic targeting at varies infectious pathogens and pioneered the technology for tuberculosis molecule diagnosis in human blood.
Email：tl.office@tonglibio.com | 
*
Submit
|
COPYRIGHT (©) Tongli Biomedical Co. (TLB) Reserved
|
Technical support: Three to Five Interconnection
|
TOP